AI‑Powered Drug Analysis Gains Ground Amid Growing Concerns Over Online Pharmacy Safety

In a rapidly evolving digital health landscape, the intersection of artificial intelligence and pharmaceutical commerce is drawing attention from regulators, clinicians, and consumers alike. A Bridge Between Evidence and Practice: The Rise of AI‑Enabled Decision Support Over the past year, Abridge’s latest partnership with the New England Journal of Medicine and JAMA Network has set … Continue reading AI‑Powered Drug Analysis Gains Ground Amid Growing Concerns Over Online Pharmacy Safety →